AETHLON MEDICAL INC (AEMD:NASDAQ)
$2.35 -0.04 (-1.6736%)
Analysed AETHLON MEDICAL INC (AEMD:NASDAQ) News Sources
AEMD: Hitting Key Milestones as Company Advances Clinical Study
24-03-2026
yahoo.com
Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
24-03-2026
yahoo.com
OTC Markets Hosts Virtual Investor Presentation with Jim Frakes, CEO and CFO of Aethlon Medical, and M. Marin, Senior Analyst at Zacks SCR
18-03-2026
yahoo.com
AEMD: Positive Takeaways From CEO Chat
18-03-2026
yahoo.com
Sigyn Therapeutics Issues Shareholder Update Regarding Potential Merger and Asset Sale Initiatives
13-03-2026
yahoo.com
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
13-03-2026
yahoo.com
Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities
12-03-2026
yahoo.com
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
10-03-2026
yahoo.com
Aethlon Medical to Present at the Life Sciences Investor Forum on March 12th
06-03-2026
yahoo.com
Presenting on Emerging Growth Conference 90 Day 1 on February 25; Register to live stream
24-02-2026
yahoo.com
What is the current price of AETHLON MEDICAL INC (AEMD:NASDAQ)?
The current price of AETHLON MEDICAL INC (AEMD:NASDAQ) is $2.35.
AETHLON MEDICAL INC (AEMD:NASDAQ) absolute price change since previous trading day?
The absolute price change of AETHLON MEDICAL INC (AEMD:NASDAQ) since the previous trading day is $-0.04.
AETHLON MEDICAL INC (AEMD:NASDAQ) percentage price change since previous trading day?
The percentage price change of AETHLON MEDICAL INC (AEMD:NASDAQ) since the previous trading day is -1.6736%.
What is the most recent average sentiment score for AETHLON MEDICAL INC (AEMD:NASDAQ)?
The most recent average sentiment score for AETHLON MEDICAL INC (AEMD:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for AETHLON MEDICAL INC (AEMD:NASDAQ)?
The most recent sentiment for AETHLON MEDICAL INC (AEMD:NASDAQ) is .
SEC-8K** Filing Available For AETHLON MEDICAL INC (AEMD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.